Amerigen Pharmaceuticals Inc.
Lyndhurst, NJ, United States
4
Total Recalls
0
Class I Recalls
0
Ongoing Recalls
Recalls by Amerigen Pharmaceuticals Inc.
FDA Drug
Class III
Terminated
Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle (NDC 43975-252-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerige
February 19, 2019
Amerigen Pharmaceuticals Inc.
a) 2,413 bottles b) 3,355 bottles units
FDA Drug
Class III
Terminated
Temozolomide Capsules, 180 mg, packaged in a 14 count bottles, Rx only, Mfd, by: Stason Pharmaceuticals, Inc., Irvine, CA, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ ---- NDC 43975-256-14
December 20, 2018
Amerigen Pharmaceuticals Inc.
771 bottles units
FDA Drug
Class III
Terminated
Temozolomide Capsules, 20 mg, packaged in a a) 5-count (NDC 43975-253-05) and b) 14 count (NDC 43975-253-14) bottles, Rx only, Mfd, by: Stason Pharmaceuticals, Inc., Irvine, CA, Dist. By: Amerigen Pha
December 20, 2018
Amerigen Pharmaceuticals Inc.
3552 bottles units
FDA Drug
Class III
Terminated
Temozolomide capsules, 20 mg, packaged in a) 5-count bottle(NCD 43975-253-05), b) 14-count bottle (NDC 43975-253-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerig
October 5, 2018
Amerigen Pharmaceuticals Inc.
5,232 bottles: a) 4,146 bottles; b) 1,086 bottles units